The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma Group.
暂无分享,去创建一个
J. Blay | A. Hagenbeek | P. Biron | C. Sebban | F. Chauvin | T. Bachelot | F. Gomez | T. Philip | C. Guglielmi | R. Somers
[1] J. Armitage,et al. High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Emili Montserrat,et al. A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.
[3] G. Fillet,et al. [Treatment of non-Hodgkin's lymphoma]. , 1987, Revue medicale de Liege.
[4] J. Armitage,et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. , 1987, The New England journal of medicine.
[5] A. Freedman,et al. Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation? , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] B. Coiffier,et al. Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] A. Hagenbeek,et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. , 1995, The New England journal of medicine.
[8] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[9] F. Cabanillas,et al. IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. , 1982, Blood.
[10] S. Rosenberg. Autologous bone marrow transplantation in non-Hodgkin's lymphoma. , 1987, The New England journal of medicine.
[11] G. Salles,et al. Chemotherapy of non-Hodgkin's aggressive lymphomas. , 1994, Seminars in hematology.
[12] F. Appelbaum,et al. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. , 1978, Blood.
[13] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[14] G. Tognoni. North-south asymmetry. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] P. Gaulard,et al. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] B. Coiffier,et al. Autologous hematopoietic stem cell transplantation in intermediate and high grade non-Hodgkin's lymphoma: a review. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] M. A. Tanner,et al. One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] R. Fisher,et al. Autologous bone marrow transplantation in adults with non‐Hodgkin's lymphoma: A southwest oncology group study , 1994, Hematological oncology.
[19] S. Jagannath,et al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). , 1988, Blood.
[20] D. Himmelstein,et al. PITFALLS OF PRIVATE MEDICINE: HEALTH CARE IN THE USA , 1984, The Lancet.
[21] M. Shipp. Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease? , 1994, Blood.
[22] S. Tucker,et al. ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Gordon Cook,et al. 11. Applied Categorical Data Analysis , 1988 .
[24] W. Velasquez,et al. Results of MIME salvage regimen for recurrent or refractory lymphoma. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.